BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 24659544)

  • 1. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.
    Lange C; Abubakar I; Alffenaar JW; Bothamley G; Caminero JA; Carvalho AC; Chang KC; Codecasa L; Correia A; Crudu V; Davies P; Dedicoat M; Drobniewski F; Duarte R; Ehlers C; Erkens C; Goletti D; Günther G; Ibraim E; Kampmann B; Kuksa L; de Lange W; van Leth F; van Lunzen J; Matteelli A; Menzies D; Monedero I; Richter E; Rüsch-Gerdes S; Sandgren A; Scardigli A; Skrahina A; Tortoli E; Volchenkov G; Wagner D; van der Werf MJ; Williams B; Yew WW; Zellweger JP; Cirillo DM;
    Eur Respir J; 2014 Jul; 44(1):23-63. PubMed ID: 24659544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug-resistant and extensively drug-resistant tuberculosis: a review.
    Chan ED; Iseman MD
    Curr Opin Infect Dis; 2008 Dec; 21(6):587-95. PubMed ID: 18978526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.
    Chang KC; Yew WW
    Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
    Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-resistant tuberculosis: past, present, future.
    Chiang CY; Centis R; Migliori GB
    Respirology; 2010 Apr; 15(3):413-32. PubMed ID: 20337989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis.
    Dheda K; Chang KC; Guglielmetti L; Furin J; Schaaf HS; Chesov D; Esmail A; Lange C
    Clin Microbiol Infect; 2017 Mar; 23(3):131-140. PubMed ID: 27756712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007.
    Marks SM; Flood J; Seaworth B; Hirsch-Moverman Y; Armstrong L; Mase S; Salcedo K; Oh P; Graviss EA; Colson PW; Armitige L; Revuelta M; Sheeran K;
    Emerg Infect Dis; 2014 May; 20(5):812-21. PubMed ID: 24751166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of drug resistantTB in patients with HIV co-infection.
    Pontali E; Sotgiu G; Centis R; D'Ambrosio L; Spanevello A; Migliori GB
    Expert Opin Pharmacother; 2015; 16(18):2737-50. PubMed ID: 26478945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
    Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
    Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
    Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM
    Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.
    Prasad R
    Indian J Tuberc; 2010 Oct; 57(4):180-91. PubMed ID: 21141336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Representations of MDR and XDR-TB in South African newspapers.
    Daku M; Gibbs A; Heymann J
    Soc Sci Med; 2012 Jul; 75(2):410-8. PubMed ID: 22534376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and operational value of the extensively drug-resistant tuberculosis definition.
    Migliori GB; Besozzi G; Girardi E; Kliiman K; Lange C; Toungoussova OS; Ferrara G; Cirillo DM; Gori A; Matteelli A; Spanevello A; Codecasa LR; Raviglione MC;
    Eur Respir J; 2007 Oct; 30(4):623-6. PubMed ID: 17690121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensively drug-resistant tuberculosis in the United States, 1993-2007.
    Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP
    JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control.
    Migliori GB; D'Arcy Richardson M; Sotgiu G; Lange C
    Clin Chest Med; 2009 Dec; 30(4):637-65, vii. PubMed ID: 19925959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis.
    Seung KJ; Keshavjee S; Rich ML
    Cold Spring Harb Perspect Med; 2015 Apr; 5(9):a017863. PubMed ID: 25918181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From multidrug- to extensively drug-resistant tuberculosis: upward trends as seen from a 15-year nationwide study.
    Stoffels K; Allix-Béguec C; Groenen G; Wanlin M; Berkvens D; Mathys V; Supply P; Fauville-Dufaux M
    PLoS One; 2013; 8(5):e63128. PubMed ID: 23671662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update.
    Falzon D; Jaramillo E; Schünemann HJ; Arentz M; Bauer M; Bayona J; Blanc L; Caminero JA; Daley CL; Duncombe C; Fitzpatrick C; Gebhard A; Getahun H; Henkens M; Holtz TH; Keravec J; Keshavjee S; Khan AJ; Kulier R; Leimane V; Lienhardt C; Lu C; Mariandyshev A; Migliori GB; Mirzayev F; Mitnick CD; Nunn P; Nwagboniwe G; Oxlade O; Palmero D; Pavlinac P; Quelapio MI; Raviglione MC; Rich ML; Royce S; Rüsch-Gerdes S; Salakaia A; Sarin R; Sculier D; Varaine F; Vitoria M; Walson JL; Wares F; Weyer K; White RA; Zignol M
    Eur Respir J; 2011 Sep; 38(3):516-28. PubMed ID: 21828024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.